GlassScriptPhysician profile
Vivi Tran
NPI 1578918355
$1,072.99
in general payments reported to CMS, 2019-2025
18 companies · $226 in 2025
The $226 reported for 2025 was more than what 77% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.36 · 2020: $107 · 2021: $239 · 2022: $284 · 2023: $117 · 2024: $19.27 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $361.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $280.80 | 2020-2025 | Bexsero |
| Arcutis Biotherapeutics, INC. | $145.25 | 2025 | |
| Merck Sharp & Dohme LLC | $114.73 | 2020-2023 | Vaxneuvance, Vaxelis, Rotateq |
| Adlon Therapeutics L.P. | $94.03 | 2019-2021 | |
| Sanofi Pasteur INC. | $89.42 | 2021-2023 | |
| Baxter Healthcare | $55.41 | 2022 | |
| Pfizer INC. | $52.32 | 2019 | |
| Welch Allyn | $48.49 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $29.56 | 2025 | Neffy |
| Neos Therapeutics, LP | $24.66 | 2020 | |
| Alk-Abello, INC | $23.11 | 2025 | Neffy |
| Galderma Laboratories, L.P. | $19.27 | 2024 | |
| Seqirus USA INC | $18.65 | 2023 | Flucelvax Quadrivalent |
| Kaleo, INC. | $17.66 | 2021 | |
| Tris Pharma INC | $17.47 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $15.00 | 2023 | Doc Band |
| Ironshore Pharmaceuticals INC. | $14.12 | 2019 | |
| Verrica Pharmaceuticals INC. | $13.04 | 2023 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivi Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.